share_log

4: Statement of changes in beneficial ownership of securities-Officer DOW GEOFFREY S

SEC announcement ·  May 22 08:20
Summary by Futu AI
Geoffrey S. Dow, President and CEO of 60 Degrees Pharmaceuticals, completed the purchase of 85,000 shares of the company's common stock through a series of transactions. The acquisitions occurred between April 12, 2024, and May 16, 2024, with prices ranging from $0.223 to $0.2668 per share. Following these transactions, Dow's direct holdings in the company increased to 762,625 shares. The transactions are reported as exercises or conversions of derivative securities, indicating a potential increase in the executive's stake in the company.
Geoffrey S. Dow, President and CEO of 60 Degrees Pharmaceuticals, completed the purchase of 85,000 shares of the company's common stock through a series of transactions. The acquisitions occurred between April 12, 2024, and May 16, 2024, with prices ranging from $0.223 to $0.2668 per share. Following these transactions, Dow's direct holdings in the company increased to 762,625 shares. The transactions are reported as exercises or conversions of derivative securities, indicating a potential increase in the executive's stake in the company.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.